<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Higher standard set for risk presentation</title>
	<atom:link href="http://blog.medadnews.com/index.php/2009/06/10/higher-standard-set-for-risk-presentation/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.medadnews.com/index.php/2009/06/10/higher-standard-set-for-risk-presentation/</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Mon, 23 Jan 2012 13:06:25 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: M Durand</title>
		<link>http://blog.medadnews.com/index.php/2009/06/10/higher-standard-set-for-risk-presentation/comment-page-1/#comment-24</link>
		<dc:creator>M Durand</dc:creator>
		<pubDate>Fri, 12 Jun 2009 16:57:23 +0000</pubDate>
		<guid isPermaLink="false">http://blog.medadnews.com/?p=121#comment-24</guid>
		<description>Everyone should read this DRAFT GUIDANCE carefully, as some of its provisions are problematic.  Can you really put risk information in a promotion piece headline?

If you follow every suggestion outlined, promotional pieces would confuse, not inform audiences.  In fact, they might discourage patients from visiting their doctors about a medical condition, which is hardly the FDA&#039;s intent.   

Remember though, this is a draft guidance and the FDA is encouraging comments about it.  Comments need to be submitted by the end of summer.</description>
		<content:encoded><![CDATA[<p>Everyone should read this DRAFT GUIDANCE carefully, as some of its provisions are problematic.  Can you really put risk information in a promotion piece headline?</p>
<p>If you follow every suggestion outlined, promotional pieces would confuse, not inform audiences.  In fact, they might discourage patients from visiting their doctors about a medical condition, which is hardly the FDA&#8217;s intent.   </p>
<p>Remember though, this is a draft guidance and the FDA is encouraging comments about it.  Comments need to be submitted by the end of summer.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

